Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Promega, SABiosciences offer pathway assay solution
September 2009
SHARING OPTIONS:

MADISON, Wisc.Promega Corp., a life sciences solutions provider, and SABiosciences Corp., a privately held biotechnology company, will combine their offerings to provide tools for interrogating specific cellular pathways via transcription factor reporters, the companies announced in August.
 
Under the new agreement, Promega recombinant firefly luciferase luc2 gene and a humanized Renilla luciferase (hRluc) gene the will serve as one key reporter system for SABiosciences' Cignal pathway reporter assays. The Cignal products with Promega luciferase technology are currently available in tube and plate formats for multiple pathways of biological interest.
 
Dave Martz, vice president of sales and marketing at SABiosciences, said Promega's recombinant firefly and humanized Renilla luciferases "provide the necessary levels of sensitivity for studying the effects of drugs or genetic perturbations on many interesting and biologically relevant cell types."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.